In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Surgery Partners Inc’s stock clocked out at $27.09, down -0.29% from its previous closing price of $27.17. In other words, the price has decreased by -$0.29 from its previous closing price. On the day, 1.1 million shares were traded. SGRY stock price reached its highest trading level at $28.04 during the session, while it also had its lowest trading level at $27.02.
Ratios:
To gain a deeper understanding of SGRY’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 18.59 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.73. For the most recent quarter (mrq), Quick Ratio is recorded 1.56 and its Current Ratio is at 1.71. In the meantime, Its Debt-to-Equity ratio is 1.61 whereas as Long-Term Debt/Eq ratio is at 1.55.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on March 06, 2024, initiated with a Equal Weight rating and assigned the stock a target price of $35.
On November 14, 2023, TD Cowen Upgraded its rating to Outperform which previously was Market Perform and also lowered its target price recommendation from $39 to $35.
BofA Securities Upgraded its Neutral to Buy on June 02, 2023, whereas the target price for the stock was revised from $42 to $45.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 14 ’24 when Doherty David T sold 721 shares for $28.59 per share. The transaction valued at 20,613 led to the insider holds 95,719 shares of the business.
Evans Jason Eric sold 4,840 shares of SGRY for $143,796 on Mar 13 ’24. The Chief Executive Officer now owns 459,670 shares after completing the transaction at $29.71 per share. On Mar 12 ’24, another insider, Owens Bradley R., who serves as the National Group President of the company, sold 2,783 shares for $29.82 each. As a result, the insider received 82,989 and left with 78,338 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGRY now has a Market Capitalization of 3442976512 and an Enterprise Value of 7815998976. As of this moment, Surgery’s Price-to-Earnings (P/E) ratio for their current fiscal year is 9030.00, and their Forward P/E ratio for the next fiscal year is 21.12. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 198.46. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.23 while its Price-to-Book (P/B) ratio in mrq is 1.75. Its current Enterprise Value per Revenue stands at 2.797 whereas that against EBITDA is 14.101.
Stock Price History:
Over the past 52 weeks, SGRY has reached a high of $45.79, while it has fallen to a 52-week low of $22.05. The 50-Day Moving Average of the stock is -1.14%, while the 200-Day Moving Average is calculated to be -10.97%.
Shares Statistics:
It appears that SGRY traded 959.76K shares on average per day over the past three months and 1137050 shares per day over the past ten days. A total of 126.59M shares are outstanding, with a floating share count of 73.28M. Insiders hold about 42.35% of the company’s shares, while institutions hold 66.28% stake in the company. Shares short for SGRY as of 1713139200 were 8599453 with a Short Ratio of 8.96, compared to 1710460800 on 8041591. Therefore, it implies a Short% of Shares Outstanding of 8599453 and a Short% of Float of 14.899999.
